Since the effects of INK-128 and NVP-Bez235 on human glioma cells have been characterized only marginally, we first assessed their capacity to effectively inhibit mTOR signaling in LNT-229 glioma cells at different concentrations. The gene discussed is MTOR; the disease is central nervous system cancer.